Epidemiological Trends in NASH as a Cause for Liver Transplant Way SiowDavid van der PoortenJacob George Fatty Liver Disease (SA Harrison and J George, Section Editors) 23 March 2016 Pages: 67 - 74
Extrahepatic Manifestations of Nonalcoholic Fatty Liver Disease Lisa B. VanWagnerMary E. Rinella Fatty Liver Disease (SA Harrison and J George, Section Editors) 28 March 2016 Pages: 75 - 85
Noninvasive Markers of Fibrosis and Inflammation in Nonalcoholic Fatty Liver Disease Saumya JayakumarStephen A. HarrisonRohit Loomba Fatty Liver Disease (SA Harrison and J George, Section Editors) 21 April 2016 Pages: 86 - 95
The Microbiome in Obesity, Diabetes, and NAFLD: What is Your Gut Telling Us? Leon A. AdamsMark Morrison Fatty Liver Disease (SA Harrison and J George, Section Editors) 05 April 2016 Pages: 96 - 102
NAFLD-Associated Hepatocellular Carcinoma: a Threat to Patients with Metabolic Disorders Anna Simona SasdelliLucia BrodosiGiulio Marchesini Fatty Liver Disease (SA Harrison and J George, Section Editors) 07 April 2016 Pages: 103 - 112
Nonalcoholic Steatohepatitis and Liver Transplantation Zobair M. YounossiLinda Henry Fatty Liver Disease (SA Harrison and J George, Section Editors) 07 April 2016 Pages: 113 - 116
Nonalcoholic Fatty Liver Disease: Prognosis and Progression of Disease Zachary H. HenryStephen H. CaldwellCurtis K. Argo Fatty Liver Disease (SA Harrison and J George, Section Editors) 12 April 2016 Pages: 117 - 124
Future Treatments of NASH Brent A. Neuschwander-Tetri Fatty Liver Disease (SA Harrison and J George, Section Editors) 12 April 2016 Pages: 125 - 133
Lean NAFLD: an Underrecognized Outlier Julia WattacherilArun J. Sanyal Fatty Liver Disease (SA Harrison and J George, Section Editors) 14 April 2016 Pages: 134 - 139